Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Basic): 2009-2024

Historic EPS (Basic) for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to -$2.69.

  • Fortress Biotech's EPS (Basic) rose 117.11% to $0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.11, marking a year-over-year increase of 96.41%. This contributed to the annual value of -$2.69 for FY2024, which is 68.24% up from last year.
  • Latest data reveals that Fortress Biotech reported EPS (Basic) of -$2.69 as of FY2024, which was up 68.24% from -$8.47 recorded in FY2023.
  • Fortress Biotech's EPS (Basic)'s 5-year high stood at -$0.79 during FY2021, with a 5-year trough of -$15.97 in FY2022.
  • Its 3-year average for EPS (Basic) is -$9.04, with a median of -$8.47 in 2023.
  • In the last 5 years, Fortress Biotech's EPS (Basic) plummeted by 1,921.52% in 2022 and then spiked by 68.24% in 2024.
  • Over the past 5 years, Fortress Biotech's EPS (Basic) (Yearly) stood at -$1.43 in 2020, then skyrocketed by 44.76% to -$0.79 in 2021, then crashed by 1,921.52% to -$15.97 in 2022, then skyrocketed by 46.96% to -$8.47 in 2023, then surged by 68.24% to -$2.69 in 2024.